Asterias Biotherapeutics: 2Q Earnings Snapshot
FREMONT, Calif. (AP) _ Asterias Biotherapeutics Inc. (AST) on Thursday reported a loss of $7 million in its second quarter.
On a per-share basis, the Fremont, California-based company said it had a loss of 13 cents. Losses, adjusted for non-recurring costs, were 10 cents per share.
The results matched Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was also for a loss of 10 cents per share.
The stem cell therapy developer posted revenue of $109,000 in the period.
In the final minutes of trading on Thursday, the company’s shares hit $1.58. A year ago, they were trading at $3.30.